证券记录 · 已归档季度
GKOS
Glaukos Corporation · Healthcare · Medical - Devices
16被追踪持有人
-1Δ持有人
9.74M持有股份
$1.46B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -5.9% ·
股份流向 +6.8% ·
净新建仓位 -6.2%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 125 | +9 | 42.85M | $5.95B | +15 | −5 |
| Q1 2026 | 118 | -1 | 46.55M | $5.02B | +6 | −8 |
| Q4 2025 | 118 | 0 | 48.22M | $5.44B | +2 | −1 |
| Q3 2025 | 22 | +5 | 29.69M | $2.42B | +5 | −1 |
| Q2 2025 | 15 | -2 | 32.65M | $3.37B | +1 | −3 |
| Q1 2025 | 14 | -2 | 8.81M | $867.57M | +1 | −3 |
| Q4 2024 | 16 | -1 | 9.74M | $1.46B | — | −1 |
| Q3 2024 | 16 | 0 | 7.06M | $919.99M | +1 | −1 |
| Q2 2024 | 16 | — | 6.75M | $798.69M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.16M | -1.1% | $323.80M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.16M | -1.1% | $323.80M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.16M | -1.1% | $323.80M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.16M | -1.1% | $323.80M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.16M | -1.1% | $323.80M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (被动) | 2.06M | — | $309.39M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 1.21M | -2.5% | $182.08M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 1.20M | +2.1% | $179.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Geode Capital Management ✦ (被动) | 1.20M | +2.1% | $179.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 1.19M | +231.8% | $178.84M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.19M | +231.8% | $178.84M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 12 | Norges Bank ✦ (被动) | 563.49K | +5.9% | $84.49M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Capital World Investors ✦ | 550.32K | 0.0% | $82.52M | 0.0% | Held | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 393.22K | +62.3% | $58.96M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 280.31K | -26.9% | $42.03M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 49.60K | +30.6% | $7.44M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 35.18K | +13.7% | $5.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 23.40K | -86.5% | $3.51M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 7.59K | +16.2% | $1.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 7.59K | +16.2% | $1.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 7.59K | +16.2% | $1.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 5.82K | -30.5% | $872,651 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | GAMCO Investors ✦ | 5.21K | -1.2% | $781,037 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 2.70K | +73.1% | $404,988 | 0.0% | ▲ Add | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Marshall Wace | $16.78M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 333 持有人, 57.55M 股份, $6.09B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 19
Kliman Gilbert H
Director · 2.50K 股 · $475,000
Aug 11
Gilliam Joseph E
Officer · 27.96K 股 · $5.00M
Aug 11
Gilliam Joseph E
Officer · 32.04K 股 · $5.78M
Aug 07
Thurman Alex R.
Officer · 20.00K 股 · $3.60M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据